Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

533904

registered interest
date	08/07/2016
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Medicine: Research
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, in the light of the result of the referendum on the UK's membership of the EU, what plans they have for maintaining the UK's status as a leader in EU and international collaboration on research into rare diseases such as muscular dystrophy and neuromuscular conditions.
tabling member printed	Baroness Thomas of Winchester
uin	HL1085
answer	answer is ministerial correction date of answer 14/07/2016 answer text <p>The Government recognises the importance of our research base, which is why we have protected the ring fenced science resource budget in real terms from its current level of £4.7bn for the rest of the parliament. Programmes such as the £1.5bn Global Challenges Research Fund and the £1bn Ross Fund will support the UK’s status as a global leader in medical research.</p><p> </p><p>The Global Challenges Research Fund will mobilise the UK’s world leading research base to address key challenges facing developing countries, including in health research. The Ross Fund will develop, test and deliver a range of new products (including vaccines, drugs and diagnostics) to help combat the world’s most serious diseases in developing countries.</p><p> </p><p>The referendum result has no immediate effect on the right of researchers to apply to or participate in EU research programmes. UK participants can continue to apply to the programmes in the usual way. The future of UK access to these programmes will be determined as part of a wider discussion with the EU.</p> answering member printed Baroness Neville-Rolfe grouped question UIN HL1087 question first answered 14/07/2016 12:52:48 answering member 4284 label Biography information for Baroness Neville-Rolfe
tabling member	3785 label Biography information for Baroness Thomas of Winchester

533906

registered interest
date	08/07/2016
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Medicine: Research
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, in the light of the result of the referendum on the UK's membership of the EU, what measures they plan to take to ensure the UK's continued participation in EU-wide data sharing initiatives for clinical trial development and condition-specific patient registries.
tabling member printed	Baroness Thomas of Winchester
uin	HL1087
answer	answer is ministerial correction date of answer 14/07/2016 answer text <p>The Government recognises the importance of our research base, which is why we have protected the ring fenced science resource budget in real terms from its current level of £4.7bn for the rest of the parliament. Programmes such as the £1.5bn Global Challenges Research Fund and the £1bn Ross Fund will support the UK’s status as a global leader in medical research.</p><p> </p><p>The Global Challenges Research Fund will mobilise the UK’s world leading research base to address key challenges facing developing countries, including in health research. The Ross Fund will develop, test and deliver a range of new products (including vaccines, drugs and diagnostics) to help combat the world’s most serious diseases in developing countries.</p><p> </p><p>The referendum result has no immediate effect on the right of researchers to apply to or participate in EU research programmes. UK participants can continue to apply to the programmes in the usual way. The future of UK access to these programmes will be determined as part of a wider discussion with the EU.</p> answering member printed Baroness Neville-Rolfe grouped question UIN HL1085 question first answered 14/07/2016 12:52:48 answering member 4284 label Biography information for Baroness Neville-Rolfe
tabling member	3785 label Biography information for Baroness Thomas of Winchester

451574

registered interest
date	09/02/2016
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what additional financial assistance he has given to universities to carry out medical research.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	26478
answer	answer is ministerial correction date of answer 24/02/2016 answer text <table><tbody><tr><td colspan="2"><p>The Medical Research Council provides funding for medical research to UK institutes, including universities. The table below sets out funding awarded in 2014/15. <strong>Medical Research Council Expenditure for 2014/15, by Organisation type, £k</strong></p></td></tr><tr><td><p><strong>Organisation type</strong></p></td><td><p><strong>Total £k</strong></p></td></tr><tr><td><p>Charity Partnership</p></td><td><p>£11,659</p></td></tr><tr><td><p>Higher Education Institution</p></td><td><p>£450,856</p></td></tr><tr><td><p>Higher Education Institution/Independent Research Organisation</p></td><td><p>£742</p></td></tr><tr><td><p>MRC Institutes/Units</p></td><td><p>£202,296</p></td></tr><tr><td><p>Independent Research Organisation</p></td><td><p>£9,695</p></td></tr><tr><td><p>UK Government Body</p></td><td><p>£21,386</p></td></tr><tr><td><p><strong>Total</strong></p></td><td><p><strong>£696,632</strong></p></td></tr></tbody></table><p> </p><p>The Higher Education Funding Council for England (HEFCE) also allocates research funding to institutions. HEFCE’s quality-related research funding (QR) is allocated as an un-hypothecated block grant, which institutions are free to invest according to their own priorities. It is a matter for individual Higher Education Institutions to determine how it is ultimately distributed to particular activities/subjects.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Orpington answering member printed Joseph Johnson question first answered 24/02/2016 10:33:30 answering member 4039 label Biography information for Lord Johnson of Marylebone
tabling member	4131 label Biography information for Jim Shannon

451576

registered interest
date	09/02/2016
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what financial assistance the Government has granted to medical companies for medical research.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	26476
answer	answer is ministerial correction date of answer 23/02/2016 answer text <p>In the last five years, Innovate UK has committed over £212 million in support of companies commercialising medical research. This includes helping companies to deliver products and services to support people living independently, funding cost-effective treatments, the development of long-term relief and cures for diseases, and commercialising new medical devices, diagnostics and solutions.</p><p>Additionally, Innovate UK, through its Catapult network, provides business access to leading-edge technology and expertise in Cell and Gene Therapy, Precision Medicine and Medicines Technologies.</p><p>Companies investing in medical research may also be eligible for the Research and Development Tax Credit, which provided £1.75bn of support in 2013/14.</p><p> </p> answering member constituency Orpington answering member printed Joseph Johnson question first answered 23/02/2016 18:30:28 answering member 4039 label Biography information for Lord Johnson of Marylebone
tabling member	4131 label Biography information for Jim Shannon

451577

registered interest
date	09/02/2016
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what steps he is taking to ensure UK universities are closely co-ordinating their medical research.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	26480
answer	answer is ministerial correction date of answer 17/02/2016 answer text <p>My Department funds medical research in universities via the Medical Research Council (MRC). The MRC supports and encourages collaboration between UK universities across all of its funding programmes, and also supports collaboration through targeted initiatives such as:</p><ul><li>The Farr Institute, which is jointly funded by the MRC, Government and research charities and brings together 19 university partners to create a UK-wide platform for health informatics research. The Institute provides the physical and electronic infrastructure to facilitate collaboration across the partner universities, and support their safe use of patient and research data for medical research.</li><li>MRC support for 13 stratified medicine research consortia, addressing conditions such as arthritis, chronic obstructive pulmonary disease, schizophrenia and dementia. The initiative involves 32 UK universities, with each consortia involving around 7 universities.</li></ul><p> </p><p>Working together, the Research Councils have developed an RCUK framework for principles in funding multi-institutional collaborations in research. Further details on the framework can be found here: <a href="http://www.rcuk.ac.uk/funding/principles/" target="_blank">http://www.rcuk.ac.uk/funding/principles/</a>.</p><p>Innovate UK also works with universities to drive translation of university-based research and innovation into commercial applications which tackle disease and life-threatening illnesses. Additionally, Innovate UK, through the Catapult network, provides access to leading-edge technology, facilities and expertise in Cell and Gene Therapy, Precision Medicine and Medicines Technologies.</p><p> </p><p> </p> answering member constituency Orpington answering member printed Joseph Johnson question first answered 17/02/2016 15:23:43 answering member 4039 label Biography information for Lord Johnson of Marylebone
tabling member	4131 label Biography information for Jim Shannon

446488

registered interest
date	20/01/2016
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Medicine: Research
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they have taken to ensure parity between funding for physical health and mental health research following the 2014 Research Excellence Framework conducted by the Higher Education Funding Council for England.
tabling member printed	Lord Crisp
uin	HL5260
answer	answer is ministerial correction date of answer 04/02/2016 answer text <p>The Higher Education Funding Council for England (HEFCE) is allocated funding from the Department for Business Innovation and Skills (BIS) Science and Research budget to distribute to higher education institutions (HEIs) in England. Most of HEFCE’s funding is allocated as an unhypothecated research block grant to institutions, ensuring university leaders have flexibility to support their own research priorities. While this block grant is calculated using research quality and volume information from the 2014 Research Excellence Framework (REF2014) at a subject level, it is a matter for individual HEIs to determine how it is ultimately distributed to particular activities/subjects.</p><p> </p><p>In developing the REF, the attribution of different disciplines to particular units of assessment was agreed with the relevant professional bodies. Research relevant to clinical mental health was assessed in a unit including psychology, psychiatry and neuroscience. As this unit included a mix of research with higher costs (clinical psychology and psychiatry, and neuroscience) and lower costs (social psychology), the funding was allocated at an intermediate cost rate, reflecting the mix of disciplines.</p><p> </p><p>REF2014 demonstrated significantly improved research quality in all disciplines, including psychology, psychiatry and neuroscience. As a result, the funding allocated on the basis of performance to this group increased by 16.5 per cent.</p><p> </p><p>As announced in the Spending Review 2015, the Government is taking forward a review of the REF to ensure that future university research funding is allocated efficiently, offers greater rewards for excellent research and reduces the administrative burden on institutions. This review will be led by Lord Stern, and he is expected to deliver his review to the Government in summer 2016.</p><p> </p><p><strong> </strong></p> answering member printed Baroness Evans of Bowes Park question first answered 04/02/2016 15:39:38 answering member 4329 label Biography information for Baroness Evans of Bowes Park
tabling member	3783 label Biography information for Lord Crisp

388081

registered interest
date	07/07/2015
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what assessment he has made of the benefits of supporting medical research and development to the (a) UK science sector, (b) NHS and (c) economy.
tabling member constituency	Stevenage
tabling member printed	Stephen McPartland
uin	5853
answer	answer is ministerial correction date of answer 15/07/2015 answer text <p /> <p>In 2014 the HEFCE supported Research Excellence Framework conducted the largest ever assessment of academic research impact. A selection of just 10 of the 1600 impact case studies submitted to the clinical sciences REF panel were found to contribute roughly £2 billion in economic benefit between 2008 and 2012.</p><p> </p><p>Work to systematically collect details of the output from all research council funded work has established a national database of more than 1 million reports of achievements linked to more than £40 billion of public and charity funded research projects, which is proving to be a comprehensive approach to describe the benefits of supporting not only medical research but research across all disciplines. More than 100 research organisations are now subscribing to this approach including the National Institute of Health Research (NIHR) and Cancer Research UK.</p><p> </p><p>Recent academic studies in to the returns to medical research estimated the returns to the UK economy from cardiovascular research at 39% and returns from cancer research at 40%. There is ongoing further research to refine these estimates.</p><p> </p><p>Finally, the UK is one of world’s strongest performers in Health and Medical Science research and is ranked 1<sup>st</sup> in field weighted citation index for Health &amp; Medical science research of comparator nations. In 2012, the UK accounted for 8.9% of all Health and Medical Science publications (2<sup>nd</sup> out of comparator nations) and for 16% of the top 1% most highly cited research (2<sup>nd</sup> out of comparator nations).</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/07/2015 10:56:57 answering member 4020 label Biography information for George Freeman
tabling member	4093 label Biography information for Stephen McPartland

388084

registered interest
date	07/07/2015
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what comparative assessment he has made of Government support for medical research and development in the UK and other major economies.
tabling member constituency	Stevenage
tabling member printed	Stephen McPartland
uin	5869
answer	answer is ministerial correction date of answer 13/07/2015 answer text <p><strong>Every two years, the Department for Business, Innovation and Skills commissions an international comparison of the UK research base. The most recent report, “<em>International Comparative Performance of the UK Research Base – 2013</em>”, assesses the performance of the UK compared with seven other research-intensive countries (Canada, China, France, Germany, Italy, Japan, and the US). Where data is available, it also makes comparisons with the EU27, OECD member countries’ groups, and three other fast growing nations (Brazil, Russia and India). The report showed that while the UK represents just 0.9% of the global population, it accounts for 3.2% of R&amp;D expenditure, 4.1% of researchers, 6.4% of research articles, 9.5% of research article downloads and 15.9% of the world's most highly-cited articles. Some of the data is broken down by subject area, showing that UK research publications in the fields of health and medical sciences and clinical sciences increased their citation impact between 2008 and 2012, and are well above the world average.</strong></p><p> </p> answering member constituency Orpington answering member printed Joseph Johnson question first answered 13/07/2015 14:03:11 answering member 4039 label Biography information for Lord Johnson of Marylebone
tabling member	4093 label Biography information for Stephen McPartland

225955

registered interest
date	09/03/2015
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what assessment he has made of reasons for regional per capita disparities in the distribution of medical research funding.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	226852
answer	answer is ministerial correction date of answer 19/03/2015 answer text <p>The Department for Business, Innovation and Skills has not made any assessment of reasons for differences in regional per capita distribution of Research Council funding. Research Council funding is awarded on the basis of the excellence of the research proposal assured through peer view.</p><p> </p><p> </p><p> </p> answering member constituency Tunbridge Wells answering member printed Greg Clark grouped question UIN 226853 question first answered 19/03/2015 16:19:01 answering member 1578 label Biography information for Greg Clark previous answer version 49430 answering member constituency Tunbridge Wells answering member printed Greg Clark answering member 1578 label Biography information for Greg Clark
tabling member	4124 label Biography information for Chi Onwurah